OppenheimerFunds’s Diebold Nixdorf Incorporated DBD Stock Holding History

OppenheimerFunds’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$2.9M	Sell	262,184 -571,611	-69%	-$4M	﹤0.01%	820
2018 Q4	$2.08M	Buy	833,795 +145,480	+21%	+$522K	﹤0.01%	856
2018 Q3	$3.1M	Buy	688,315 +454,399	+194%	+$3.31M	﹤0.01%	835
2018 Q2	$2.79M	Buy	233,916 +152,200	+186%	+$2.04M	﹤0.01%	849
2018 Q1	$1.26M	Buy	81,716 +1,215	+2%	+$20.3K	﹤0.01%	989
2017 Q4	$1.32M	Buy	80,501 +22,933	+40%	+$443K	﹤0.01%	1061
2017 Q3	$1.32M	Buy	57,568 +16,935	+42%	+$361K	﹤0.01%	1072
2017 Q2	$1.14M	Buy	40,633 +2,328	+6%	+$64.4K	﹤0.01%	1131
2017 Q1	$1.18M	Buy	38,305 +7,158	+23%	+$202K	﹤0.01%	1119
2016 Q4	$783K	Sell	31,147 -23,857	-43%	-$563K	﹤0.01%	1174
2016 Q3	$1.36M	Buy	55,004 +14,484	+36%	+$385K	﹤0.01%	949
2016 Q2	$1.01M	Buy	40,520 +25,655	+173%	+$661K	﹤0.01%	1003
2016 Q1	$430K	Sell	14,865 -781	-5%	-$20.4K	﹤0.01%	1285
2015 Q4	$471K	Buy	+15,646	New	+$532K	﹤0.01%	1309

Other funds holding DBD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

OppenheimerFunds's DBD Position: Q1 2019 in Review

OppenheimerFunds reduced its Diebold Nixdorf Incorporated (DBD) stake by 69% in Q1 2019, selling an estimated $4M and leaving 262,184 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #820.

OppenheimerFunds first reported a position in DBD in Q4 2015 and has held it in 14 quarters since. The position peaked at $3.1M in Q3 2018. 204 funds tracked by Wall St. Rank hold DBD as of Q1 2019.

OppenheimerFunds held 262,184 shares of Diebold Nixdorf Incorporated worth $2.9M as of Q1 2019.
OppenheimerFunds sold 571,611 Diebold Nixdorf Incorporated shares in Q1 2019, an estimated $4M.
Diebold Nixdorf Incorporated made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #820 holding.
OppenheimerFunds first reported a position in Diebold Nixdorf Incorporated in Q4 2015 and has held it in 14 quarters since.
OppenheimerFunds's Diebold Nixdorf Incorporated position peaked at $3.1M in Q3 2018.
204 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.